BIO-key Reports Third Quarter 20...(732-359-1113 Investor Contact: DRG...)
Navigation Links
BIO-key Reports Third Quarter 2007 Results
Date:11/14/2007
732-359-1113
Investor Contact: DRG&E
Gus Okwu, Managing Director
404-892-8178
'/>"/>
| SOURCE BIO-key International, Inc. Copyright©2007 PR Newswire. All rights reserved |
Related biology news :
1. BIO-key Reports Second Quarter 2007 Results
2. BIO-key(R) Announces Contracts for New Criminal Justice Data Sharing Solution
3. BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo
4. Radiant Systems Selects BIO-key(R) Biometric Software for POS Solution
5. Radiant Systems Selects BIO-key(R) Biometric Software for POS Solution
6. BIO-key(R) International to Showcase Deployed Biometric Security Applications at 2007 Biometric Technology Expo
7. Youngstown, Ohio Police Award Mobile Data Contract to BIO-key(R) International
8. BIO-key International Showcasing Innovative Public Safety Solutions at 2007 IACP Conference
9. ACT Ensures Integrity of Testing Process Through Deployment of BIO-keys(R) Biometric ID Technology
10. Easton, PA Police Officers Armed With BIO-key(R) Mobile Data Solution Access Information Anytime, Anywhere
11. Communication Intelligence Corporation Reports Second Quarter 2007 Financial Results
Post Your Comments:
Breaking Biology News(10 mins):Rodent smoke screen 2Superior offspring without genetic modification 2Plate-eating good: Université de Montréal professor designs edible tableware 2United Concordia Dental Expands Benefit Options 56006 1United Concordia Dental Expands Benefit Options 56006 2BioMarin to Present at the Thomas Weisel Partners Healthcare Conference 56001 1BioMarin to Present at the Thomas Weisel Partners Healthcare Conference 56001 2MEDA Receives FDA Approval of New ASTEPRO 28R 29 28azelastine HCl 29 Nasal Spray 0 15 25 the First and Only Once Daily Nasal Antihistamine 55998 1MEDA Receives FDA Approval of New ASTEPRO 28R 29 28azelastine HCl 29 Nasal Spray 0 15 25 the First and Only Once Daily Nasal Antihistamine 55998 2MEDA Receives FDA Approval of New ASTEPRO 28R 29 28azelastine HCl 29 Nasal Spray 0 15 25 the First and Only Once Daily Nasal Antihistamine 55998 3MEDA Receives FDA Approval of New ASTEPRO 28R 29 28azelastine HCl 29 Nasal Spray 0 15 25 the First and Only Once Daily Nasal Antihistamine 55998 4MEDA Receives FDA Approval of New ASTEPRO 28R 29 28azelastine HCl 29 Nasal Spray 0 15 25 the First and Only Once Daily Nasal Antihistamine 55998 5
Other Biology News:Building strong bones: Running may provide more benefits than resistance training, MU study finds 2MIT: Using touch to help deaf people 2Self-digestion as a means of survival 2
Breaking Biology Technology:Cell Biosciences Acquires Protein Forest 2ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 2ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 3ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 4Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 2Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 3Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 4BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 2BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement 3
[0] Cell Biosciences Acquires Protein Forest[0] ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis[0] Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A[0] BioLife Solutions Announces Custom cGMP Manufacturing & License Agreement
Other Biology Technology:SulphCo Adds New Board Member 2Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE(R) 2Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE(R) 3Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 2Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |